| Several pharmaceutical companies and academic institutions in the west             have come into conflict with Indian academic institutions and             traditional Ayurvedic practitioners over the intellectual property             rights of herbal products researched by the western agencies. The             Ayurvedic practitioners have known about the efficacy of such products             for centuries and so contend that they carry precedence with regards             to patent rights on such products.
 In December 1993, the University of Mississippi Medical Center had a             patent issued to them by US Patents and Trademarks office on the use             of turmeric (US Patent No. 5,401,504) for healing. The patent was             contested by India's industrial research organization, Council for             Scientific and Industrial Research (C.S.I.R), on the grounds that             traditional Ayurvedic practitioners were already aware of the healing             properties of the substance and have been for centuries, making this             patent a case of bio-piracy.
 
 After a complex legal battle, the US PTO ruled on August 14, 1997 that             the patent was invalid because it was not a novel invention, giving             the intellectual property rights to the principle back to the             traditional practitioners of Ayurveda. R. A. Mashelkar,             director-general of the CSIR, was satisfied with the result, saying:
 
 "This success will enhance the confidence of the people and help             remove fears about India's helplessness on preventing bio-piracy and             appropriation of inventions based on traditional knowledge”
 
 Vandana Shiva, a global campaigner for a fair and honest Intellectual             Property Rights system, says patents on herbal products derived from             Neem, Amla, Jar Amla, Anar ("Pomegranate"), Salai, Dudhi ("Calabash"),             Gulmendhi, Bagbherenda, Karela, Erand, Rangoon-kibel, Vilayetishisham             and Chamkura also need to be revoked.
 
 Seven American and four Japanese firms have filed for grant of patents             on formulations containing extracts of the herb Ashwagandha. Fruits,             leaves and seeds of the Indian medicinal plant withania somnifera have             been traditionally used for the Ayurvedic system as aphrodisiacs,             diuretics and for treating memory loss. The Japanese patent             applications are related to the use of the herb as a skin ointment and             for promoting reproductive fertility. The U.S based company Natreon             has also obtained a patent for an Ashwagandha extract. Another US             establishment, the New England Deaconess Hospital, has taken a patent             on an Ashwagandha formulation claimed to alleviate symptoms associated             with arthritis. It is clear that the Ashwagandha plant is catching the             attention of scientists and more patents related to Ashwagandha are             being filed or granted by different patent offices since 1996.
 
 Ayurvedic wisdom originated in the main Vedas as a part of way of life             - a spiritual connection with spirit and nature. This is most evident             reading Atharva Veda. Ayurveda was used to remove obstacles on one’s             path to Self-Realization. At some point the medical aspects began to             take priority over the spiritual forms of healing (ie, focusing on             lifestyle, dharma and moksha. Today, these spiritual aspects of             Ayurveda have taken a back seat to the medical focus. As Ayurveda             becomes a more commercially viable career, the spiritual aspects may             continue to lose ground. Yet there are a growing number of             practitioners who practice mainly these spiritual therapies and find             better results than limiting their approach to the medical, physical             realm.
 |